Arcticzymes Technologies ASA banner

Arcticzymes Technologies ASA
OSE:AZT

Watchlist Manager
Arcticzymes Technologies ASA Logo
Arcticzymes Technologies ASA
OSE:AZT
Watchlist
Price: 23.5 NOK
Market Cap: kr1.2B

Gross Margin

95.8%
Current
Improving
by 0.8%
vs 3-y average of 95.1%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
95.8%
=
Gross Profit
kr107.9m
/
Revenue
kr112.6m

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
95.8%
=
Gross Profit
kr107.9m
/
Revenue
kr112.6m

Peer Comparison

Country Company Market Cap Gross
Margin
NO
Arcticzymes Technologies ASA
OSE:AZT
1.2B NOK
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
409.4B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
197.3B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
179.1B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.8B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81B USD
Loading...
AU
CSL Ltd
ASX:CSL
70.3B AUD
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
NL
argenx SE
XBRU:ARGX
38B EUR
Loading...

Market Distribution

Higher than 95% of companies in Norway
Percentile
95th
Based on 655 companies
95th percentile
95.8%
Low
-3 145.8% — 7.6%
Typical Range
7.6% — 59.8%
High
59.8% — 1 122%
Distribution Statistics
Norway
Min -3 145.8%
30th Percentile 7.6%
Median 38.1%
70th Percentile 59.8%
Max 1 122%

Arcticzymes Technologies ASA
Glance View

Market Cap
1.2B NOK
Industry
Biotechnology

ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. The company is headquartered in Tromso, Troms. The company went IPO on 2005-11-04. The firm focuses on new solutions within molecular research, in vitro diagnostics and therapeutics. Arcticzymes Technologies ASA invests in BetaGlucans, which develops immunomodulating beta-glucan products, serving several different market segments including wound care, animal and consumer health and adjuvants.

AZT Intrinsic Value
15.63 NOK
Overvaluation 34%
Intrinsic Value
Price
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
95.8%
=
Gross Profit
kr107.9m
/
Revenue
kr112.6m
What is Arcticzymes Technologies ASA's current Gross Margin?

The current Gross Margin for Arcticzymes Technologies ASA is 95.8%, which is above its 3-year median of 95.1%.

How has Gross Margin changed over time?

Over the last 3 years, Arcticzymes Technologies ASA’s Gross Margin has decreased from 96.2% to 95.8%. During this period, it reached a low of 94% on Sep 30, 2024 and a high of 96.2% on Dec 31, 2022.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett